sb 203580 has been researched along with pyrithione in 1 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (pyrithione) | Trials (pyrithione) | Recent Studies (post-2010) (pyrithione) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 163 | 3 | 40 |
| Protein | Taxonomy | sb 203580 (IC50) | pyrithione (IC50) |
|---|---|---|---|
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 0.05 | |
| large T antigen | Betapolyomavirus macacae | 30.26 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Araragi, S; Higashimoto, M; Kondoh, M; Sato, M; Takiguchi, M; Tasaki, E; Watanabe, Y | 1 |
1 other study(ies) available for sb 203580 and pyrithione
| Article | Year |
|---|---|
Requirement of caspase and p38MAPK activation in zinc-induced apoptosis in human leukemia HL-60 cells.
Topics: Apoptosis; Blotting, Western; Caspases; Cell Death; Cell Line; Dose-Response Relationship, Drug; Enzyme Inhibitors; HL-60 Cells; Humans; Imidazoles; In Situ Nick-End Labeling; Ionophores; Leukemia; Mitogen-Activated Protein Kinases; Necrosis; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; Thiones; Time Factors; Zinc | 2002 |